Create a new high ground for medical transformation and open a new chapter for Shenzhen-Hong Kong cell therapy. The Cell Therapy Transformation Research Institute of Shenzhen Hospital of Southern Medi
On January 22, 2025, the opening ceremony of the Cell Therapy Transformation Research Institute jointly built by Shenzhen Hospital of Southern Medical University and Shenzhen Cell Valley Biomedicine Co., Ltd. was held in Shenzhen Hospital of Southern Medical University. The activity was presided over by Vice President Chen Ye. Lin Zhenzhong, Deputy Director of Shenzhen Qianhai Administration Bureau, Wang Huanyu, Professor Shi Yuanyuan, Chairman and general manager of Shenzhen Cell Valley, Professor Wang Jianxun, Chief scientist and Deputy General Manager Tang Xiaomeng, Famous Hong Kong philanthropist Cheng Kam-chung, Chairman of the Greater China Cancer Foundation, Chen Yisheng, Vice Chairman of the Hong Kong Biotechnology Association, and David Jin, former professor of Cornell University Medical College in the United States, were invited to attend the event.
Shenzhen Hospital of Southern Medical University is the only hospital directly affiliated to the university in Qianhai Free Trade Zone that can simultaneously undertake the tasks of medical teaching and research. As the first "famous hospital" project of Shenzhen Medical and health "Three projects", it enjoys the policy advantage of "first and first trial" and is also the bridgehead of Southern Medical University's "Shenzhen Strategy". Has been committed to the innovation of medical technology and the transformation of scientific research results
At the unveiling ceremony, Zhou Hongwei, president of Shenzhen Hospital of Southern Medical University, said that the establishment of the Cell therapy Transformation Research Institute in cooperation with Shenzhen Cell Valley Biomedicine Co., Ltd. is an important step for the hospital in the field of cell therapy. The Institute will build an innovation platform integrating scientific research, transformation and training, increase resource investment around key research areas of cell therapy, and gradually build academic research heights. Form a model of close cooperation between research PI and clinical departments, promote cell therapy technology from laboratory to clinical, and build a pilot cell therapy in Shenzhen Qianhai; Jointly establish a talent training base for the industrialization of cell therapy, carry out multi-level and multi-form talent training projects, and train research-oriented, production-oriented and quality-controlled talents for the industry.
Mr. Shi Yuanyuan, chairman of Shenzhen Cell Valley Biomedical Co., LTD., said that as a major project in Shenzhen and a major public service platform for Shenzhen's biomedical industry, Shenzhen Cell Valley is a one-stop comprehensive program provider in the field of cell and gene therapy, with profound technology accumulation and international vision. The alliance with Shenzhen Hospital of Southern Medical University will inject impetus into the innovation and development of cell therapy. We hope that through the establishment of the Institute, we can achieve fruitful scientific research and clinical results, build the most distinctive cell therapy and industrial transformation platform in Shenzhen and even the whole country, bring good news to more patients, and provide continuous impetus for the development of the hospital. And contribute to the economic development of Shenzhen.
The establishment of the Cell Therapy Transformation Institute will rely on the respective advantages of Shenzhen Hospital of Southern Medical University and Shenzhen Cell Valley to add new impetus to Shenzhen-Hong Kong cooperation in cell therapy in the Guangdong-Hong Kong-Macao Greater Bay Area, and establish cooperative relationships with domestic and foreign scientific research institutions and enterprises, striving to become a new plateau in the field of cell therapy innovation, leading cell therapy technology breakthroughs, and promoting clinical treatment means innovation. To bring safer and more effective medical services to patients in Shenzhen, Hong Kong and even at home and abroad.
